David Krempa | VP, Business Development |
Sean Brynjelsen | CEO |
Wilson Troutman | CFO |
Ram Selvaraju | H.C. Wainwright |
Good afternoon, and welcome to the Eton Pharmaceuticals Second Quarter 2019 Financial and Operating Results Conference Call. At this time, all participants are in a listen-only mode.
Following the formal remarks, we will open the call up for your questions. Please be advised that this call is being recorded at the Company's request.
At this time, I'd like to turn the call over to David Krempa, Vice President of Business Development at Eton Pharmaceuticals.